Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform (Q46247292)

20 December 2017

title

Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform (English)

1 reference

20 December 2017

Human Induced Pluripotent Stem Cells

main subject

1 reference

1 reference

Yusheng Qu

1

1 reference

20 December 2017

Hugo M Vargas

series ordinal

2

1 reference

20 December 2017

publication date

27 June 2015

1 reference

20 December 2017

published in

Toxicological Sciences

1 reference

20 December 2017

volume

147

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

286-295

1 reference

20 December 2017

Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment

cites work

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Electrophysiologic basis for the antiarrhythmic actions of ranolazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Combination of functional cardiomyocytes derived from human stem cells and a highly-efficient microelectrode array system: an ideal hybrid model assay for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

High throughput measurement of Ca²⁺ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Action potential morphology of human induced pluripotent stem cell-derived cardiomyocytes does not predict cardiac chamber specificity and is dependent on cell density

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Dofetilide: a new pure class III antiarrhythmic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

The 'overly-sensitive' heart: sodium channel block and QRS interval prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

MICE models: superior to the HERG model in predicting Torsade de Pointes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Stem cell-derived cardiomyocytes as a tool for studying proarrhythmia: a better canary in the coal mine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Rechanneling the cardiac proarrhythmia safety paradigm: a meeting report from the Cardiac Safety Research Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Role of ranolazine in angina, heart failure, arrhythmias, and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Early afterdepolarizations and cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFV128

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFV128

1 reference

20 December 2017

PubMed ID

26117837

1 reference

20 December 2017